HBM Healthcare Investments Reports 15% NAV Increase in 2024

HBM Healthcare Investments AG concluded 2024 with a notable increase in its net asset value (NAV) per share. The NAV rose by 15% to CHF 251.17. In contrast, the share price saw only a slight rise of 0.5%, reaching CHF 176.00. This discrepancy suggests a market capitalization almost CHF 500 million below the NAV, reflecting the full book value of private company portfolios.

Private companies played a crucial role in this growth, with significant events like Johnson & Johnson acquiring Yellow Jersey Therapeutics and the IPO of Sai Life Sciences in India. Additionally, the appreciation of investment currencies against the Swiss franc contributed 6.8% to the NAV rise.

Market indices in healthcare also grew, yet they underperformed compared to HBM's results. The MSCI World Health Care Index increased by 9.9%, and the Nasdaq Biotechnology Index by 7.6%.